1
Clinical Trials associated with Normoxic Allogenic UCMSC(PT Bifarma Adiluhung) / Unknown statusPhase 2/3IIT Efficacy and Safety of Normoxic Allogenic Umbilical Cord Mesenchymal Stem Cells Administered as Adjuntive Treatment to Standard Treatment in Severe Patients With COVID-19
This study is conducted to assess the efficacy and safety of stem cells as adjunctive treatment for severe COVID-19 patients. Here, we want to study whether the administration of mesenchymal stem cells are safe and able to relieve some of the COVID-19 symptoms
100 Clinical Results associated with Normoxic Allogenic UCMSC(PT Bifarma Adiluhung)
100 Translational Medicine associated with Normoxic Allogenic UCMSC(PT Bifarma Adiluhung)
100 Patents (Medical) associated with Normoxic Allogenic UCMSC(PT Bifarma Adiluhung)
100 Deals associated with Normoxic Allogenic UCMSC(PT Bifarma Adiluhung)